Rupa Prasad, MD
Pain Medicine · San Diego, CANPI 1689037384
Payments from drug & device makers
Across 213 payments — averaging $69.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Medtronic$5K
- Abbott$801
- SPR Therapeutics, Inc$326
- UCB, Inc.$319
- AbbVie$309
- plus $2K from 33 others
What the payments were for
- Grants$9,00061%
- Travel & lodging$1591%
- Food & beverage$5,60438%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 40 | $6,485 |
| Medtronic(2 entities) | 10 | $4,636 |
| Abbott | 29 | $801 |
| SPR Therapeutics, Inc | 14 | $326 |
| UCB, Inc. | 12 | $319 |
| AbbVie | 15 | $309 |
| Biohaven Pharmaceutical Holding Company Ltd. | 20 | $215 |
| Lilly USA, LLC | 9 | $165 |
| Nevro Corp. | 4 | $116 |
| GRT US Holding, Inc. | 2 | $93 |
| Nalu Medical, Inc. | 4 | $89 |
| Merz North America, Inc. | 2 | $85 |
| Lundbeck LLC | 4 | $78 |
| Upsher-smith Laboratories LLC | 3 | $75 |
| Sanofi | 4 | $74 |
| Averitas Pharma Inc. | 3 | $71 |
| Pfizer | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Neurocrine Biosciences, Inc. | 2 | $57 |
| SK Life Science, Inc. | 2 | $54 |
| Merz Pharmaceuticals, LLC | 1 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $42 |
| Biogen | 2 | $41 |
| EMD Serono, Inc. | 2 | $40 |
| AstraZeneca | 1 | $33 |
| Vertos Medical, Inc. | 1 | $32 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Chiesi USA, Inc. | 1 | $29 |
| Neurelis, Inc. | 1 | $24 |
| Painteq LLC | 1 | $23 |
| Novartis | 1 | $22 |
| Bioventus LLC | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Amgen | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Impel Pharmaceuticals LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$5,000
- SYNCHROMED$4,000
- GENERAL PAIN MANAGEMENT$380
- WaveWriter Alpha Prime 16$157
- RESTORE$150
- KYPHON EXPRESS II KYPHOPAK TRAY$110
- ETERNA$101
How this compares
$14,763 in reported general payments places this provider in the 85th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 25 | $2,957 |
| Pregabalin | 61 | $1,277 |
| Gabapentin | 98 | $1,035 |
| Duloxetine Hcl | 26 | $314 |
| Tizanidine Hcl | 15 | $136 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in San Diego
- Nathaniel SchusterSan Diego$366K
- Mark WallaceSan Diego$340K
- Gemayel LeeSan Diego$131K
- Clayton VargaSan Diego$112K
- Jessica OswaldSan Diego$90K
- Kevin SmithSan Diego$80K
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.